Kadri Saks

Tallinn, Estonia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse.

Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse.

Journal: Pediatric blood & cancer

Published: December 10, 2025

Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO-DBH AML study.

Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO-DBH AML study.

Journal: British journal of haematology

Published: May 05, 2025

Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13).

Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13).

Journal: Genes, chromosomes & cancer

Published: May 11, 2024

Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.

Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 11, 2024

Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 protocol.

Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 protocol.

Journal: Haematologica

Published: February 17, 2024

Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia.

Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia.

Journal: British journal of haematology

Published: November 29, 2022

Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium.

Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium.

Journal: Expert review of anticancer therapy

Published: October 03, 2022

Estimation of cefepime, piperacillin, and tazobactam clearance with iohexol-based glomerular filtration rate in paediatric patients.

Estimation of cefepime, piperacillin, and tazobactam clearance with iohexol-based glomerular filtration rate in paediatric patients.

Journal: European journal of clinical pharmacology

Published: December 01, 2021

Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia.

Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia.

Journal: Leukemia

Published: March 13, 2021

Glomerular filtration rate in children and young adults with haemato-oncological disease and infection is best described by three-compartment iohexol model.

Glomerular filtration rate in children and young adults with haemato-oncological disease and infection is best described by three-compartment iohexol model.

Journal: Pediatric blood & cancer

Published: February 05, 2021

Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.

Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.

Journal: Thrombosis research

Published: April 14, 2020

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use.

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use.

Journal: Journal of medical biochemistry

Published: April 08, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026